View in EDS HTML Full Text PDF Full Text

Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy.

Saved in:
Bibliographic Details
Title: Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy.
Authors: Liang, Guanghao1,2 (AUTHOR), Wang, Linchen1,2 (AUTHOR), You, Qiancheng3,4 (AUTHOR), Cahill, Kirk5 (AUTHOR), Chen, Chuanyuan1,2 (AUTHOR), Zhang, Wei6,7 (AUTHOR), Fulton, Noreen5,8 (AUTHOR), Stock, Wendy5,8 (AUTHOR), Odenike, Olatoyosi5,8 (AUTHOR) todenike@medicine.bsd.uchicago.edu, He, Chuan3,4,9 (AUTHOR) chuanhe@uchicago.edu, Han, Dali1,2,10 (AUTHOR) handl@big.ac.cn
Source: Advanced Science. 8/15/2023, Vol. 10 Issue 23, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21983844
DOI:10.1002/advs.202300445